Other Viruses Citation List: March 28 - April 10, 2014
Hepatitis B Virus
1. Taraxacum mongolicum Extract Exhibits a Protective Effect on Hepatocytes and an Antiviral Effect against Hepatitis B Virus in Animal and Human Cells. Jia, Y.Y., R.F. Guan, Y.H. Wu, X.P. Yu, W.Y. Lin, Y.Y. Zhang, T. Liu, J. Zhao, S.Y. Shi, and Y. Zhao. Molecular Medicine Reports, 2014. 9(4): p. 1381-1387; PMID[24481875].
[PubMed]. OV_0328-041014.
2. Inhibition of Hepatitis B Virus Replication by Ligand-mediated Activation of RNase L. Park, I.H., Y.C. Kwon, W.S. Ryu, and B.Y. Ahn. Antiviral Research, 2014. 104: p. 118-127; PMID[24509240].
[PubMed]. OV_0328-041014.
Hepatitis C Virus
3. New Antiviral Agents for the Treatment of Hepatitis C: ABT-450. Carrion, A.F., J. Gutierrez, and P. Martin. Expert Opinion on Pharmacotherapy, 2014. 15(5): p. 711-716; PMID[24517400].
[PubMed]. OV_0328-041014.
4. New Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C in 2014. Cornberg, M., C. Honer Zu Siederdissen, B. Maasoumy, and M.P. Manns. Der Internist, 2014. 55(4): p. 390-400; PMID[24652513].
[PubMed]. OV_0328-041014.
5. Cholesterol Sulfate as a Potential Inhibitor of Hepatitis C Virus NS3 Helicase. Furuta, A., K.A. Salam, N. Akimitsu, J. Tanaka, H. Tani, A. Yamashita, K. Moriishi, M. Nakakoshi, M. Tsubuki, Y. Sekiguchi, S. Tsuneda, and N. Noda. Journal of Enzyme Inhibition and Medicinal Chemistry, 2014. 29(2): p. 223-229; PMID[23432541].
[PubMed]. OV_0328-041014.
6. Ledipasvir : A Novel Synthetic Antiviral for the Treatment of HCV Infection. Gentile, I., A.R. Buonomo, F. Borgia, G. Castaldo, and G. Borgia. Expert Opinion on Investigational Drugs, 2014. 23(4): p. 561-571; PMID[24593285].
[PubMed]. OV_0328-041014.
7. PBDE: Structure-activity Studies for the Inhibition of Hepatitis C Virus NS3 Helicase. Salam, K.A., A. Furuta, N. Noda, S. Tsuneda, Y. Sekiguchi, A. Yamashita, K. Moriishi, M. Nakakoshi, H. Tani, S.R. Roy, J. Tanaka, M. Tsubuki, and N. Akimitsu. Molecules, 2014. 19(4): p. 4006-4020; PMID[24699145].
[PubMed]. OV_0328-041014.
Epstein-Barr Virus
8. Small Molecule Inhibition of Epstein-Barr Virus Nuclear Antigen-1 DNA Binding Activity Interferes with Replication and Persistence of the Viral Genome. Lee, E.K., S.Y. Kim, K.W. Noh, E.H. Joo, B. Zhao, E. Kieff, and M.S. Kang. Antiviral Research, 2014. 104: p. 73-83; PMID[24486954].
[PubMed]. OV_0328-041014.
Citations from the ISI Web of Knowledge Listings for O.V.
9. Cytomegalovirus Mutants Resistant to Ganciclovir and Cidofovir Differ in Susceptibilities to Synguanol and Its 6-Ether and 6-Thioether Derivatives. Chou, S.W., G. Komazin-Meredith, J.D. Williams, and T.L. Bowlin. Antimicrobial Agents and Chemotherapy, 2014. 58(3): p. 1809-1812; ISI[000332175100075].
[WOS]. OV_0328-041014.